Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

VETMEDIN DIN 02248159

Status: Marketed
Holder: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Molecule: PIMOBENDAN

Health Canada record

Active ingredient(s)PIMOBENDAN 5 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date20-Nov-2003
Current status date13-Oct-2020
SourceHealth Canada DPD

Establishment licence of the holder

Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing PIMOBENDAN

DINProductCompanyFormStrengthStatus
02248158VETMEDINBOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.CapsulePIMOBENDAN 2.5 MGMarketed
02248211VETMEDINBOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.CapsulePIMOBENDAN 1.25 MGMarketed
02469480VETMEDIN 1.25 MG CHEWABLE TABLETSBOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.Tablet (Chewable)PIMOBENDAN 1.25 MGApproved
02469464VETMEDIN 10 MG CHEWABLE TABLETSBOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.Tablet (Chewable)PIMOBENDAN 10 MGApproved
02469499VETMEDIN 2.5 MG CHEWABLE TABLETSBOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.Tablet (Chewable)PIMOBENDAN 2.5 MGApproved
02469502VETMEDIN 5 MG CHEWABLE TABLETSBOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.Tablet (Chewable)PIMOBENDAN 5 MGApproved

Notices of Compliance

NOCDateSubmissionReason
244182020-10-13New Drug Submission (NDS)Administrative: Change in Product Ownership
178782016-03-16Supplement to a New Drug Submission (SNDS)NEW INDICATION
88882007-07-05Supplement to a New Drug Submission (SNDS)CHANGE IN MANUFACTURER OF THE ACTIVE INGREDIENT
34012003-09-19New Drug Submission (NDS)
Request a quote for VETMEDIN

How to read a Canadian DIN record